Cancer patients’ experiences with immune checkpoint modulators: A qualitative study

BACKGROUND: Minimal qualitative data exist on the experiences of cancer patients treated with immune checkpoint inhibitors or costimulatory antibodies. Understanding the day to day experiences of patients being treated with immune checkpoint modulators, and how these relate to their health‐related q...

Descripción completa

Detalles Bibliográficos
Autores principales: Ala‐Leppilampi, Kari, Baker, Natalie A., McKillop, Chris, Butler, Marcus O., Siu, Lillian L., Spreafico, Anna, Abdul Razak, Albiruni R., Joshua, Anthony M., Hogg, David, Bedard, Philippe L., Leighl, Natasha, Oza, Amit M., Parsons, Janet A., Hansen, Aaron R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196048/
https://www.ncbi.nlm.nih.gov/pubmed/32119767
http://dx.doi.org/10.1002/cam4.2940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196048/
https://www.ncbi.nlm.nih.gov/pubmed/32119767
http://dx.doi.org/10.1002/cam4.2940

Ejemplares similares